Vical Incorporated Message Board

I'm surprised Theodore Cohen didn't mention the 50 day coming up through the 200. He talked about the technical aspect but didnt mention this. It should happen this week and the stock will really start to spike.

Sentiment: Buy

yep vaxfectin is the money maker but everybody is missing the real capability of vaxfectin

Big Pharma likes vaccines

Sanofi Pasteur MSD – high profile role responsible for the launch of a new first in class product for the UK market

Requirements:

BACKGROUND

Sanofi Pasteur MSD is the only company in the UK totally dedicated to vaccines. With a heritage that includes pioneers in vaccination, such as Louis Pasteur (rabies vaccine) and Maurice Hilleman (measles vaccine), they have grown to become a leading supplier of vaccines.

Using a combination of research and manufacturing expertise, their purpose is to bring innovative vaccines to the UK, protecting health and preserving quality of life for all ages.



PRIMARY DUTIES

You will support a new first in class vaccines for the prevention of herpes zoster (“zoster” or shingles) and herpes zoster related post herpetic neuralgia (PHN) in individuals 50 years of age and older.

Reporting to the Medical Director, in this high profile role you will take overall responsibility for the direction and provision of medical support to the Company’s commercial activities, both internally and externally, primarily through opinion leader development and working with the Market Access and Marketing teams.

Experienced candidates will be offered line management opportunities.

QUALIFICATIONS / EXPERIENCE REQUIRED:

You will be medically qualified with GMC registration with relevant clinical experience. You will be able to demonstrate a successful track record in Medical Affairs within the pharmaceutical industry. However, physicians with a Public Health background seeking to move into the industry will be considered.

They should have included shareholders in the guinea pig study

"... vaxfectin formulated plasmid dna vaccine against herpes simplex virus type 2." the real-deal adjuvant. great potential!

Sentiment: Buy

I'm so excited. Melanoma cancer testing started in 2006 and today is 2013. We just need to wait another 7 years or less for this study?